Literature DB >> 24952419

Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ).

M T Carrillo-de-la-Peña1, Y Triñanes, A González-Villar, S Romero-Yuste, C Gómez-Perretta, M Arias, F Wolfe.   

Abstract

(1) To assess the degree of convergence between the 1990 and 2010 American College of Rheumatology (ACR) diagnostic criteria; (2) To evaluate the validity and reliability of the 2010 ACR criteria; (3) To validate the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ); and (4) To assess the utility of the FSQ to differentiate fibromyalgia (FM) subgroups by disease severity. In the first study, agreement between the 1990 and 2010 ACR criteria for FM diagnosis was analyzed in a sample of 80 FM patients and 59 healthy controls. Algometry (mean threshold and tender points count) and the 2010 ACR indices [Symptom Severity Scale (SSS), Widespread Index (WPI) and Polysymptomatic Distress Scale (PSD)] were correlated with the key symptoms of FM and with indices of disease interference and quality of life. In a second study, we evaluated the validity and internal consistency of the Spanish version of the FSQ, as well as its ability to discriminate between groups of FM patients with low and high symptom severity. There is good agreement between the 1990 and 2010 ACR criteria for FM diagnosis. The 2010 ACR indices (SSS, WPI and PSD) demonstrated very adequate construct validity and appeared to be useful in the assessment of disease severity and global impact of FM. The FSQ had good internal consistency and validity and showed 100 % concordance with 2010 ACR criteria applied by a clinician. In addition, the FSQ proved to be useful in differentiating FM severity subgroups.

Entities:  

Mesh:

Year:  2014        PMID: 24952419     DOI: 10.1007/s00296-014-3074-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

Review 1.  Translating instruments into other languages: development and testing processes.

Authors:  Ann Hilton; Myriam Skrutkowski
Journal:  Cancer Nurs       Date:  2002-02       Impact factor: 2.592

2.  Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Authors:  Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

3.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

6.  Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM.

Authors:  D Buskila; L Neumann
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

7.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

8.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

9.  Diagnosis and differential diagnosis of fibromyalgia.

Authors:  Don L Goldenberg
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

10.  The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Pantelis Panopalis; Henri Ménard; Yoram Shir; Fred Wolfe
Journal:  BMC Musculoskelet Disord       Date:  2012-09-20       Impact factor: 2.362

View more
  18 in total

Review 1.  A narrative review on the difficulties associated with fibromyalgia diagnosis.

Authors:  Dinesh Kumbhare; Sara Ahmed; Scott Watter
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-12-07       Impact factor: 5.346

2.  The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity.

Authors:  Frederick Wolfe; Brian T Walitt; Johannes J Rasker; Robert S Katz; Winfried Häuser
Journal:  J Rheumatol       Date:  2015-06-15       Impact factor: 4.666

3.  A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management.

Authors:  Sheryl Bourgaize; Genevieve Newton; Dinesh Kumbhare; John Srbely
Journal:  J Can Chiropr Assoc       Date:  2018-04

4.  Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population.

Authors:  Ali Bidari; Banafsheh Ghavidel-Parsa; Alireza Amir Maafi; Ali Montazeri; Babak Ghalehbaghi; Amir Hassankhani; Yasaman Aarabi; Afrooz Haghdoost
Journal:  Rheumatol Int       Date:  2015-08-08       Impact factor: 2.631

5.  Active and sham transcranial direct current stimulation (tDCS) improved quality of life in female patients with fibromyalgia.

Authors:  N Samartin-Veiga; A J González-Villar; M Pidal-Miranda; A Vázquez-Millán; M T Carrillo-de-la-Peña
Journal:  Qual Life Res       Date:  2022-03-01       Impact factor: 3.440

6.  Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study).

Authors:  Albert Feliu-Soler; Xavier Borràs; María T Peñarrubia-María; Antoni Rozadilla-Sacanell; Francesco D'Amico; Rona Moss-Morris; Matthew A Howard; Nicolás Fayed; Carles Soriano-Mas; Marta Puebla-Guedea; Antoni Serrano-Blanco; Adrián Pérez-Aranda; Raffaele Tuccillo; Juan V Luciano
Journal:  BMC Complement Altern Med       Date:  2016-02-27       Impact factor: 3.659

Review 7.  Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

8.  Broad cognitive complaints but subtle objective working memory impairment in fibromyalgia patients.

Authors:  Marina Pidal-Miranda; Alberto Jacobo González-Villar; María Teresa Carrillo-de-la-Peña; Elena Andrade; Dolores Rodríguez-Salgado
Journal:  PeerJ       Date:  2018-11-21       Impact factor: 2.984

9.  Increased neural noise and impaired brain synchronization in fibromyalgia patients during cognitive interference.

Authors:  A J González-Villar; N Samartin-Veiga; M Arias; M T Carrillo-de-la-Peña
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

10.  The efficacy of adding group behavioral activation to usual care in patients with fibromyalgia and major depression: design and protocol for a randomized clinical trial.

Authors:  Lydia Gómez-Pérez; Alvaro Vergés; Ana Rocío Vázquez-Taboada; Josefina Durán; Matías González Tugas
Journal:  Trials       Date:  2018-11-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.